U.S. Markets closed

CTI BioPharma Corp. (CTIC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.2500+0.0300 (+1.35%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.81
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.1300
52 Week Low 30.8600
50-Day Moving Average 33.1300
200-Day Moving Average 33.1502

Share Statistics

Avg Vol (3 month) 3822.95k
Avg Vol (10 day) 33.15M
Shares Outstanding 593.09M
Implied Shares Outstanding 6N/A
Float 57.1M
% Held by Insiders 10.22%
% Held by Institutions 147.17%
Shares Short (Apr 14, 2021) 41.72M
Short Ratio (Apr 14, 2021) 41.04
Short % of Float (Apr 14, 2021) 42.25%
Short % of Shares Outstanding (Apr 14, 2021) 41.85%
Shares Short (prior month Mar 14, 2021) 4401.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 02, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jan 02, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-52.10%
Return on Equity (ttm)-180.99%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -43.04M
Net Income Avi to Common (ttm)-52.45M
Diluted EPS (ttm)-0.7370
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)52.45M
Total Cash Per Share (mrq)0.68
Total Debt (mrq)7.45M
Total Debt/Equity (mrq)18.61
Current Ratio (mrq)3.19
Book Value Per Share (mrq)0.53

Cash Flow Statement

Operating Cash Flow (ttm)-42.2M
Levered Free Cash Flow (ttm)-26.29M